TriangleNCT01258998 · OUTCOME
Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- From the start of treatment to death or 30 days after removal from the study whichever occurs first
What was measured
Number of surviving participants without disease progression or death for any reason at one year post treatment. Kaplan-Meier method was used.
Analysis population: PI is not available, therefore, no data is available for reporting in this section due to the overall survival was not an outcome to be measured initially. All efforts were made to retrieve data.
Groups in this outcome
Akt Inhibitor MK2206
Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
| Group | Source count |
|---|---|
| Akt Inhibitor MK2206 | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- Number of surviving participants without disease progression or death for any reason at one year post treatment. Kaplan-Meier method was used.
- groups
- description
- Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
- id
- OG000
- title
- Akt Inhibitor MK2206
- population Description
- PI is not available, therefore, no data is available for reporting in this section due to the overall survival was not an outcome to be measured initially. All efforts were made to retrieve data.
- reporting Status
- POSTED
- time Frame
- From the start of treatment to death or 30 days after removal from the study whichever occurs first
- title
- Overall Survival
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice